Comparing Conventional Grid Laser Photocoagulation and Subthreshold Micropulse Laser in Diabetic Macular Edema Using OCT Angiography
NCT05416099 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-06-13
Summary
The prevalence of diabetes mellitus has increased significantly in Hong Kong for the past decade \[1\]. Diabetic macular edema is one of the most common causes of vision loss in patients suffering from diabetes mellitus \[3\]. Before the introduction of anti-vascular endothelial growth factor agents, laser photocoagulation has been the mainstay treatment for patients with diabetic macular edema. There are two types of laser treatment modalities, namely focal laser, which can be applied either in a grid pattern over a region of macular edema or to selected microaneurysms, and subthreshold micropulse laser. Only one meta-analysis published in 2016 \[16\] had previously demonstrated superiority of micropulse laser over focal laser, while other studies showed no clinically significant differences between the two lasers. Nevertheless, micropulse laser had been proven to cause no structural changes to the retina and choroid, as opposed to focal laser.
Optical coherence tomography angiography (OCT-A) is a new, non-invasive imaging technique that allows a clear, depth-resolved visualization of the retinal and choroidal microvasculature in the macular region \[22\]. A recent case series study \[17\] has demonstrated early changes of retinal vasculature on OCT-A images after micropulse laser for diabetic macular edema. Another cross-sectional study \[18\] showed choriocapillaries alterations in some of the patients after receiving focal laser. We would like to compare the changes of different OCT-A parameters for patients receiving either type of laser, and hence evaluating their efficacy.
We propose to take OCT-A images for patients before laser, 1-, 3- and 6-months post-laser based on the results of a recent case series \[17\]. We will analyse the OCT-A images with MATLAB software and compare the changes in different parameters between both lasers.
Conditions
Interventions
- PROCEDURE
-
laser
grid vs micropulse laser
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Principal Investigators
-
Gabriel HK Li, M.B. Ch.B · CUHK
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2022-12-01
- Completion
- 2022-12-01
Countries
- China
Study Locations
More Related Trials
-
To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema
NCT02462304 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema
NCT03571659 ·Status: COMPLETED
-
577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema
NCT02406157 ·Status: COMPLETED ·Phase: NA
-
Short-pulse Subthreshold vs Infrared Micropulse for Diabetic Macular Edema
NCT04505306 ·Status: COMPLETED ·Phase: NA
-
Micropulse Laser Photocoagulation in Diabetic Macular Edema
NCT07266597 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema
NCT01355692 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular Edema
NCT01928654 ·Status: UNKNOWN ·Phase: NA
-
Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR
NCT04103671 ·Status: RECRUITING ·Phase: NA
-
Home Monitoring of Diabetic Macular Edema
NCT05223569 ·Status: UNKNOWN ·Phase: NA
-
Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
NCT07295704 ·Status: RECRUITING
-
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema
NCT04359771 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
NCT05759884 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers of Diabetic Retinopathy Progression
NCT01607190 ·Status: COMPLETED
-
Comparison of Initial Treatment in With Laser Grid in Diabetic Macular Edema to Intra Vitreal Avastin Injections
NCT01769599 ·Status: UNKNOWN
-
Grid Laser for Diffuse Diabetic Maculopathy
NCT02555956 ·Status: COMPLETED
-
Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema
NCT00069056 ·Status: COMPLETED ·Phase: PHASE1
-
Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy
NCT01196325 ·Status: UNKNOWN
-
Observational Study of DME Following Scatter Laser Photocoagulation
NCT00687154 ·Status: COMPLETED ·Phase: NA
-
The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes
NCT03150654 ·Status: COMPLETED ·Phase: NA
-
Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration
NCT02569892 ·Status: COMPLETED ·Phase: NA
-
Early Laser Treatment for Diabetic Eye Disease in China : A Pilot Randomized Trial
NCT02956759 ·Status: UNKNOWN ·Phase: NA
-
Laser and Antioxidant Treatment of Diabetic Macular Edema
NCT00055042 ·Status: COMPLETED ·Phase: PHASE1
-
Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED).
NCT02650050 ·Status: TERMINATED ·Phase: NA
-
OCT-angiography in Diabetic Patients
NCT02870803 ·Status: UNKNOWN
-
Micropulse for Suppression of Diabetic Macular Edema
NCT03519581 ·Status: COMPLETED ·Phase: NA